Aaron I. Davis, Director, 10% Owner at Rain Therapeutics Inc. (RAIN), bought 1,175,000 shares at $15.58 ($19.8M) on 2021-04-23, disclosed to the SEC on 2021-04-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.58 | 25,000 | $390K | 2.0% |
| 2 | $16.27 | 125,000 | $2.0M | 10.2% |
| 3 | $17.00 | 1,025,000 | $17.4M | 87.8% |
| Total | $16.89 avg | 1,175,000 | $19.8M | 100% |
| Filing → |
| TYRA | SELL | 2023-02-13 | $4.4M | — | Filing → |
| RAIN | BUY | 2022-11-08 | $11.3M | — | Filing → |
| ITOS | SELL | 2022-05-11 | $20.2M | — | Filing → |